Jim Cramer Says He “Believed in” Bristol-Myers’ Cobenfy But “It’s Not Selling Well at All”

Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer recently shared thoughts on. Cramer showed his disappointment in the company’s schizophrenia medicine sales, as he commented: “Look, I, my Charitable Trust owns Bristol, looks like a mistake because I, I believed in Cobenfy, which is a, a pretty good product, but it’s not selling well at all.” Source: Unsplash Bristol-Myers Squibb Company (NYSE:BMY) develops biopharmaceutical products for cancer, cardiovascular, autoimmune, and ne ...